Table 3:
Overlaps between CNVRs identified in this study and those from previous published reports
| Study | Platform | No. chr. | No. breeds, samples, and CNVRs | % Overlap with CNVRs identified in this study | ||||
|---|---|---|---|---|---|---|---|---|
| A | B | C | D | ABCD | ||||
| Fadista et al. [15] | CGH-based | 29+X | 4; 20; 266 | 12.0 | 16.9 | 13.9 | 11.3 | 18.0 |
| Liu et al. [16] | 29+X | 17; 90; 223 | 65.5 | 78.0 | 71.7 | 57.4 | 78.9 | |
| Hou et al. [22] | SNP-based (50K chip) | 29 | 21; 521; 743 | 35.8 | 48.0 | 35.1 | 30.6 | 51.1 |
| Bae et al. [23] * | 29 | 1; 265; 224 | 16.5 | 29.0 | 14.3 | 10.3 | 33.9 | |
| Hou et al. [24] | 29 | 1; 472; 500 | 21.0 | 31.8 | 21.0 | 16.6 | 35.6 | |
| Jiang et al. [25] | 22 | 1; 2,047; 64 | 31.2 | 48.4 | 25.0 | 21.9 | 48.4 | |
| Hou et al. [26] | SNP-based (HD chip) | 29 | 27; 674; 3,438 | 19.4 | 28.4 | 20.5 | 15.4 | 33.0 |
| Wu et al. [27] | 29+X | 1; 792; 263 | 38.8 | 49.8 | 39.2 | 29.3 | 54.4 | |
| Bickhart et al. [28] | WGS | 29 | 3; 5; 763 | 10.6 | 14.4 | 11.1 | 9.3 | 16.0 |
| Zhan et al. [29] | 29 | 1; 1; 419 | 8.1 | 11.5 | 8.4 | 9.5 | 13.8 | |
| Stothard et al. [17] | 26 | 2; 2; 634 | 12.3 | 15.1 | 13.2 | 11.7 | 16.2 | |
| Keel et al. [18] | 29+X | 7; 154; 1,341 | 60.8 | 66.4 | 64.0 | 56.3 | 67.2 | |
| Chen et al. [19] | 29+X | 2; 316; 16,325 | 6.7 | 10.7 | 8.1 | 5.5 | 12.2 | |
| Mean % overlap | 26.05 | 34.49 | 26.58 | 21.93 | 36.82 | |||
| No. of breeds, samples, and CNVRs identified in this study | 5; 72; 6,864 | 16; 287; 10,928 | 6; 131; 8,056 | 1; 29; 5,749 | 17; 517; 9,482 | |||
*For studies that used the Btau 4.0 assembly for mapping, we used the UCSC liftOver tool [33] to convert the genomic coordinates of the CNVRs to UMD 3.1.